Suchergebnisse - "Mutimer, David"

PubPharm (203)

1

Rate and determinants of antiviral treatment initiation for patients with HBeAg-negative chronic hepatitis B

enthalten in: Journal of viral hepatitis | 2023

von Mutimer, D. | Elsharkawy, A. | Hathorn, E. | +1

2

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals : population based cohort study

enthalten in: BMJ (Clinical research ed.) | 2023

von Hamill, V. | Wong, S. | Benselin, J. | +28

3

Age, ethnicity and proximity to clinic determine retention in care of chronic hepatitis B patients

enthalten in: Journal of viral hepatitis | 2023

von Mutimer, D. | Elsharkawy, A. | Hathorn, E. | +1

4

Rate and determinants of antiviral treatment initiation for patients with HBeAg‐negative chronic hepatitis B

enthalten in: Journal of Viral Hepatitis | 2023

von Mutimer, D. | Elsharkawy, A. | Hathorn, E. | +1

5

Hepatitis B e antigen and e antibody in a multi-ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years

enthalten in: Journal of viral hepatitis | 2022

von Mutimer, D. | Elsharkawy, A. | Hathorn, E. | +1

6

Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa

enthalten in: The Journal of infectious diseases | 2022

von Aranday-Cortes, E. | McClure, C. | Davis, C. | +12

7

The Weapons State : Proliferation and the Framing of Security

Erschienen: Boulder, Lynne Rienner Publishers, [2022]

von Mutimer, D.

8

Hepatitis B e antigen and e antibody in a multi‐ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years

enthalten in: Journal of Viral Hepatitis | 2022

von Mutimer, D. | Elsharkawy, A. | Hathorn, E. | +1

9

An experience using historical hepatitis C data to Re-Engage : Possibilities and pitfalls during the COVID-19 pandemic

enthalten in: Public health in practice (Oxford, England) | 2021

von Osborne, W. | Sheikh, N. | Botterill, G. | +4

10

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence

enthalten in: The American journal of gastroenterology | 2021

von Zamor, P. | Brown, A. | Dylla, D. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]